Related Experiment Video
Updated: Jan 14, 2026

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
Published on: June 28, 2024
A Case of Cerebral Folate Deficiency due to FOLR1 Mutation in a 10-Year-Old Girl: Clinical Presentation and Treatment
Farzad Ahmadabadi1,2, Mahsa Heidari-Foroozan3, Seyed Amin Jazayeri2
1Pediatric Neurology Research Center Shahid Beheshti University of Medical Sciences Tehran Iran.
Insights
Cerebral folate deficiency (CFD) in a child was caused by a FOLR1 gene mutation, impairing brain folate transport. Folinic acid treatment significantly improved her developmental regression and refractory seizures.
Area of Science:
- Neurology
- Genetics
- Biochemistry
Background:
- Cerebral folate deficiency (CFD) is a neurological disorder characterized by low folate levels in the cerebrospinal fluid (CSF).
- It often presents with developmental delay, regression, and intractable seizures, particularly in children.
- Impaired folate transport across the blood-brain barrier is a key pathogenic mechanism.
Purpose of the Study:
- To report a case of pediatric CFD due to a FOLR1 gene mutation.
- To highlight the diagnostic utility of genetic testing in CFD.
- To demonstrate the therapeutic efficacy of folinic acid in this condition.
Main Methods:
- Case report of a 10-year-old girl with developmental regression and refractory seizures.
- Whole exome sequencing to identify genetic cause.
- Initiation of folinic acid supplementation based on diagnosis.
Main Results:
- A pathogenic mutation in the FOLR1 gene was identified, confirming CFD.
- The patient experienced significant clinical improvement following folinic acid treatment.
- Seizure control and developmental progress were observed post-treatment.
Conclusions:
- Genetic testing is crucial for diagnosing CFD and identifying the underlying genetic defect.
- Folinic acid supplementation is an effective treatment for CFD caused by FOLR1 mutations.
- Early diagnosis and treatment can mitigate severe neurological deficits in CFD.
Abstract:
Cerebral folate deficiency (CFD) is characterized by reduced levels of folate, particularly 5-methyltetrahydrofolate (5-MTHF), in the cerebrospinal fluid (CSF). This case report describes a 10-year-old girl diagnosed with CFD due to a pathogenic mutation in the FOLR1 gene, which impairs folate transport across the blood-brain barrier. The patient, who exhibited normal early development, experienced developmental regression and refractory seizures after the age of four. Despite treatment with multiple antiepileptic medications, her seizures remained uncontrolled. Genetic testing via whole exome sequencing confirmed the FOLR1 mutation, leading to the initiation of folinic acid supplementation. Following treatment, the patient demonstrated significant clinical improvement. This case underscores the critical role of genetic testing in diagnosing CFD and guiding effective treatment strategies, including the timely use of folinic acid to mitigate neurological deficits associated with folate transport impairments.
Related Concept Videos
Alzheimer's Disease: Treatment
Vitamins
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Inborn Errors of Metabolism

